Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Wei Lin

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Translational Medicine|May 22, 2026
Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissueYu-Tung Chen, Zih-Yu Jhuang, Pin-Jie Li, et al.
Plos One|June 23, 2017
Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-β2 expressionKo-Hsun Liao, Shing-Jyh Chang, Hsin-Chuan Chang, et al.
Theranostics|June 14, 2018
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomesYuan-Chin Hsieh, Hsin-Ell Wang, Wen-Wei Lin, et al.
Frontiers in Microbiology|November 21, 2022
Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probeChih-Hung Chuang, Tian-Lu Cheng, Wei-Chun Chen, et al.
Acta Biomaterialia|May 18, 2020
Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomesI-Ju Chen, Yi-An Cheng, Kai-Wen Ho, et al.
Scientific Reports|September 16, 2017
Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domainsI-Ju Chen, Chih-Hung Chuang, Yuan-Chin Hsieh, et al.
Journal of Biomedical Nanotechnology|January 30, 2018
Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted TherapyChih-Hung Chuang, Pao-Chu Wu, Teng-Huang Tsai, et al.
Scientific Reports|April 8, 2021
Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapyWen-Wei Lin, Yi-An Cheng, Chia-Ching Li, et al.
Bioconjugate Chemistry|November 2, 2022
Engineering a High-Affinity Anti-Methoxy Poly(ethylene glycol) (mPEG) Antibody for Sensitive Immunosensing of mPEGylated Therapeutics and mPEG MoleculesChiao-Yu Hsiao, Jun-Lun Meng, Jung-Zhe Hong, et al.
Pharmacological Research|February 6, 2022
Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesisKai-Wen Cheng, Chih-Hua Tseng, I-Ju Chen, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Translational Medicine|May 22, 2026
Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissueYu-Tung Chen, Zih-Yu Jhuang, Pin-Jie Li, et al.
Plos One|June 23, 2017
Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-β2 expressionKo-Hsun Liao, Shing-Jyh Chang, Hsin-Chuan Chang, et al.
Theranostics|June 14, 2018
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomesYuan-Chin Hsieh, Hsin-Ell Wang, Wen-Wei Lin, et al.
Frontiers in Microbiology|November 21, 2022
Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probeChih-Hung Chuang, Tian-Lu Cheng, Wei-Chun Chen, et al.
Acta Biomaterialia|May 18, 2020
Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomesI-Ju Chen, Yi-An Cheng, Kai-Wen Ho, et al.
Scientific Reports|September 16, 2017
Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domainsI-Ju Chen, Chih-Hung Chuang, Yuan-Chin Hsieh, et al.
Journal of Biomedical Nanotechnology|January 30, 2018
Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted TherapyChih-Hung Chuang, Pao-Chu Wu, Teng-Huang Tsai, et al.
Scientific Reports|April 8, 2021
Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapyWen-Wei Lin, Yi-An Cheng, Chia-Ching Li, et al.
Bioconjugate Chemistry|November 2, 2022
Engineering a High-Affinity Anti-Methoxy Poly(ethylene glycol) (mPEG) Antibody for Sensitive Immunosensing of mPEGylated Therapeutics and mPEG MoleculesChiao-Yu Hsiao, Jun-Lun Meng, Jung-Zhe Hong, et al.
Pharmacological Research|February 6, 2022
Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesisKai-Wen Cheng, Chih-Hua Tseng, I-Ju Chen, et al.
Pageof 7